Showing 1511-1520 of 1537 results for "".
- Jonathan S. Weiss, MDhttps://practicaldermatology.com/profiles/jonathan-s-weiss-md/L6Gogv/Dr. Jonathan Weiss joined Gwinnett Dermatology, P.C. and Gwinnett Clinical Research Center in 1991. He has active clinical and research interests in psoriasis, topical and systemic retinoids, photodamage, actinic keratosis, skin cancer, rosacea, infectious disease, and cosmetic dermatology. Dr. W…
- US HealthConnect, Inc. Notice at Collectionhttps://practicaldermatology.com/pages/notice-collection/US HealthConnect, Inc. Notice at Collection U.S. HealthConnect, Inc. (“USHC” or “us” or “we” or “our”) owns and operates USHealthConnect.com and the ReachMD network of websites, which includes ReachMD.com (“Sites”), as well as the ReachMD mobile applications (“Apps”). This notice at collection (“…
- Emil Tanghetti, MDhttps://practicaldermatology.com/profiles/emil-tanghetti-md/7N5rqk/He attended U.C Davis where he excelled in his studies and received early admission to UCLA School of Medicine after only three years of undergraduate studies. Upon completing his medical studies and a 1-year pathology fellowship Dr. Tanghetti graduated first in his class and received the Dean Warr…
- Joel M. Gelfand, MD, MSCEhttps://practicaldermatology.com/profiles/joel-m-gelfand-md-msce/L0vdl9/Joel M. Gelfand MD MSCE is Professor of Dermatology and Epidemiology (with tenure) at the University of Pennsylvania's Perelman School of Medicine. He is also Vice Chair of Clinical Research, Medical Director of the Dermatology Clinical Studies Unit, and Director of the Psoriasis and Phototherapy T…
- David Goldberg, MD, JDhttps://practicaldermatology.com/profiles/david-goldberg-md-jd/OXBNWa/Goldberg earned his medical degree from Yale University. He completed his dermatology residency and dermatologic surgical fellowship at New York University Medical Center. He is a clinical professor and former director of Mohs Surgery and Laser Research in the department of Dermatology at New York’…
Janssen Approvals, New Thermage FLX, Restylane Silk Cannulas
https://practicaldermatology.com/series/dermwire-tv/dermwiretv-janssen-approvals-new-thermage-flx-restylane-silk-cannulas/18401/Janssen Biotech's Stelara is now approved for the treatment of adolescents 12 years of age or older with moderate to severe plaque psoriasis who are candidates for phototherapy or systemic therapy. Janssen's SIMPONI ARIA® cleared for the treatment of adults with active psoriatic arthritis or activeSeparating Fact from Fiction: The Realities of CKD-aP
https://practicaldermatology.com/programs/cme/separating-fact-from-fiction-the-realities-of-ckd-ap/14964/Separate facts from fiction in CKD-aP! Our experts tackle this often overlooked condition and discuss ways to improve your patients’ lives.Holding Court in Melanoma: Choosing the Optimal Frontline Treatment Approach for Stage IV BRAF-Wild Type Melanoma
https://practicaldermatology.com/programs/cme/holding-court-in-melanoma-choosing-the-optimal-frontline-treatment-approach-for-stage-iv-braf-wild-type-melanoma/15436/How can we make an informed decision on which target combined with a PD-1 inhibitor provides the most benefit in patients with metastatic melanoma?Preventing Disease Recurrence with Adjuvant Therapy in Stage IIB/IIC Melanoma
https://practicaldermatology.com/programs/cme/preventing-disease-recurrence-adjuvant-therapy-stage-iibiic-melanoma/15392/Are you as excited as our experts are about immunotherapy for the adjuvant treatment of stage IIB/IIC melanoma? Tune in to find out why you should be!DermWireTV: Pulse's CellFX, Soliton's RAP Technology, Belotero Balance (+), Restylane Defyne, Eczema Costs
https://practicaldermatology.com/series/dermwire-tv/dermwiretv-pulses-cellfx-solitons-rap-technology-belotero-balance-restylane-defyne-eczema-costs/19899/The FDA has cleared Pulse Biosciences’ CellFX system, and a commercial rollout will begin soon. There’s another new option for treatment for legs with FDA clearance of Soliton’s Rapid Acoustic Pulse technology for cellulite. For eight percent of Americans with atopic dermatitis, annual out of pocket